Searched for
MOLNUPIRAVIR VACCINE
Molnupiravir doesn't help reduce deaths or hospital admissions: StudyPrevious studies among unvaccinated patients had suggested that molnupiravir could help prevent hospital admission. The latest study provid...- Molnupiravir not included in COVID-19 treatment guidelines as its harms outweigh benefits: ICMRNoting its rampant and irrational use of the pill, Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) said that e...
- Mild Covid cases can be managed at home, Molnupiravir no magic drug, says AIIMS docDr Nischal said, "Pandemic does not mean that unless your doctor prescribes multiple drugs or fancy pills you are not going to get okay. At...
- India to become hub for Covid-19 antiviral generic drugs: FitchGeneric molnupiravir will increase access in India and other low- and middle-income countries (LMICs), while simplifying current supply cha...
- India reported more than 6x bump in COVID cases in last 8 days: Health MinistryIndia has reported more than a 6.3 times increase in cases in the last 8 days, the Health Ministry said in a briefing on Wednesday. The min...
- Centre should allow vaccination of children in 12-15 age group: Maharashtra health minister Rajesh TopeTalking to reporters in Jalna after the commencement of the vaccination drive for the 15-18 age group, Rajesh Tope said the central governm...
- COVID-19: Corbevax, Covovax, Molnupiravir approved for emergency useUnion Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's C...
- A game-changing pill and two new vaccines will bolster India's fight against Covid variantsThe recommendations have been sent to the Drug Controller General of India (DCGI), which will soon decide on their approval, people in the ...
- Government panel recommends EUA for COVID-19 vaccines Covovax, Corbevax and anti-Covid pill molnupiravirThe SEC on COVID-19 of the CDSCO, which reviewed the emergency use authorisation (EUA) applications of Serum Institute of India (SII) for t...
- Experts panel to review applications of Covovax & Corbevax jabs; Merck's Covid drug todayThe subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...
- Merck v Pfizer: here's how the two new COVID antiviral drugs work and will be usedUK approved molnupiravir, the COVID antiviral developed by Merck and Ridgeback Therapeutics. Now, Pfizer has released results from trials o...
- Expert panel asks drug cos to submit subgroup data on MolnupiravirMolnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of...
- Expert panel seeks additional info on Merck's Covid-19 drugMolnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of...
- Dr. Reddy's open to making Pfizer COVID pill after Merck dealThe new drugs, which unlike vaccines can be used to treat patients once they contract coronavirus infection, are expected to be a huge mark...
- UK authorizes Merck's coronavirus pill, the first shown to be effective at treating COVID-19The pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe...
- Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravirIn a meeting held on October 4, both the companies said that they “they want to discontinue phase III trial in moderate Covid-19 patients a...
- A new oral antiviral drug for COVID-19 is being tested in humans - can it make a difference?One promising drug that could improve things is molnupiravir, an antiviral that's moving into the final stages of testing in humans. Resear...
- MSD in talks with Medicines Patent Pool for additional licenses for molnupiravirMSD entered into a voluntary licensing agreement with five Indian drug makers including Sun Pharma, Cipla, Dr. Reddy’s, Emcure and Hetero f...
- Natco Seeks emergency approval to launch Molnupiravir for Covid-19 in IndiaMolnupiravir was originally developed to treat influenza before US-based Merck initiated research to repurpose drug for use against SARS-Co...
- Do not neglect anti-Covid drugsAs the virus continues to mutate, vaccines developed for previous versions might cease to be effective. Antiviral drugs are, therefore, gai...
Load More
